Debbie M. Cheng, ScD

Professor, Biostatistics

Debbie Cheng
617.358.2525
801 Massachusetts Ave Crosstown Center

Biography

Debbie M. Cheng is Professor of Biostatistics and has been on the faculty at the School of Public Health since 2002. Her research interests include longitudinal data analyses and the design and analysis of clinical trials. She collaborates with investigators at the Boston University School of Medicine on several projects in the areas of substance abuse and HIV research. She is Principal Investigator of the Biostatistics and Data Management Core for the URBAN ARCH Consortium, a consortium of studies designed to examine the consequences of alcohol on HIV disease progression. Dr. Cheng is also Co-Director of the Biostatistics Core for the Providence/Boston Center for AIDS Research (CFAR). In addition, she serves as lead statistician on several other studies including: a randomized clinical trial of a multi-facted intervention designed to improve HIV outcomes among HIV-infected people who inject drugs in St. Petersburg, Russia (LINC-II Study) and a clinical trial testing the effectiveness of a collaborative care intervention for HIV care physicians to improve the management of chronic opioid therapy and reduce the misuse of prescription opioids among HIV-infected persons (TEACH study).  She has been an instructor for Introduction to Statistical Computing (BS723) and the Design and Conduct of Clinical Trials (BS722).

Other Positions

  • Associate Chair, Biostatistics, Boston University School of Public Health
  • Boston Medical Center
  • Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University School of Medicine

Education

  • Harvard University, ScD
  • Northwestern University, BS

Publications

  • Published on 10/5/2021

    Samet JH, Tsui JI, Cheng DM, Liebschutz JM, Lira MC, Walley AY, Colasanti JA, Forman LS, Root C, Shanahan CW, Sullivan MM, Bridden CL, Abrams C, Harris C, Outlaw K, Armstrong WS, Del Rio C. Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial. Clin Infect Dis. 2021 10 05; 73(7):e2052-e2058. PMID: 32697847.

    Read at: PubMed
  • Published on 6/1/2021

    Freiman JM, Fatch R, Cheng D, Emenyonu N, Ngabirano C, Geadas C, Adong J, Muyindike WR, Linas BP, Jacobson KR, Hahn JA. Prevalence of elevated liver transaminases and their relationship with alcohol use in people living with HIV on anti-retroviral therapy in Uganda. PLoS One. 2021; 16(6):e0250368. PMID: 34061870.

    Read at: PubMed
  • Published on 5/24/2021

    Pierre F, Forman LS, Winter M, Cheng D, Ngabirano C, Emenyonu N, Hunt PW, Huang Y, Muyindike W, Samet J, Hahn JA, So-Armah K. Alcohol Consumption and Tryptophan Metabolism Among People with HIV Prior to Antiretroviral Therapy Initiation: The Uganda ARCH Cohort Study. Alcohol Alcohol. 2021 May 24. PMID: 34027552.

    Read at: PubMed
  • Published on 5/20/2021

    Lodi S, Emenyonu NI, Marson K, Kwarisiima D, Fatch R, McDonell MG, Cheng DM, Thirumurthy H, Gandhi M, Camlin CS, Muyindike WR, Hahn JA, Chamie G. The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial. Trials. 2021 May 20; 22(1):355. PMID: 34016158.

    Read at: PubMed
  • Published on 4/21/2021

    Fuster D, Nunes D, Cheng DM, Saitz R, Samet JH. Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients. Viruses. 2021 04 21; 13(5). PMID: 33919027.

    Read at: PubMed
  • Published on 3/23/2021

    Lodi S, Freiberg M, Gnatienko N, Blokhina E, Yaroslavtseva T, Krupitsky E, Murray E, Samet JH, Cheng DM. Per-protocol analysis of the ZINC trial for HIV disease among alcohol users. Trials. 2021 03 23; 22(1):226. PMID: 33757560.

    Read at: PubMed
  • Published on 3/22/2021

    Ngo B, Liebschutz JM, Cheng DM, Colasanti JA, Merlin JS, Armstrong WS, Forman LS, Lira MC, Samet JH, Del Rio C, Tsui JI. Hazardous alcohol use is associated with greater pain interference and prescription opioid misuse among persons living with HIV and chronic pain. BMC Public Health. 2021 03 22; 21(1):564. PMID: 33752634.

    Read at: PubMed
  • Published on 3/17/2021

    Corcorran MA, Ludwig-Baron N, Cheng DM, Lioznov D, Gnatienko N, Patts G, So-Armah K, Blokhina E, Bendiks S, Krupitsky E, Samet JH, Tsui JI. The Hepatitis C Continuum of Care Among HIV-Positive Persons with Heavy Alcohol Use in St. Petersburg, Russia. AIDS Behav. 2021 Aug; 25(8):2533-2541. PMID: 33730255.

    Read at: PubMed
  • Published on 3/7/2021

    Bendiks S, Cheng DM, Blokhina E, Vetrova M, Verbitskaya E, Gnatienko N, Bryant K, Krupitsky E, Samet JH, Tsui JI. Pilot study of tolerability and safety of opioid receptor antagonists as novel therapies for chronic pain among persons living with HIV with past year heavy drinking: a randomized controlled trial. AIDS Care. 2021 Mar 07; 1-10. PMID: 33682527.

    Read at: PubMed
  • Published on 2/10/2021

    Ngwa JS, Cabral HJ, Cheng DM, Gagnon DR, LaValley MP, Cupples LA. Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study. BMC Med Res Methodol. 2021 02 10; 21(1):29. PMID: 33568059.

    Read at: PubMed

View 189 more publications: View full profile at BUMC

View all profiles